“…Molecule glue approaches to induce protein dimerization have been demonstrated into two groups: 1) Asymmetric molecules such as Cyclosporin A ( Liu et al, 1991 ), FK506 ( Liu et al, 1991 ; Ho et al, 1996 ), FKCsA ( Belshaw et al, 1996a ), rapamycin ( Rivera et al, 1996 ), gibberellin ( Miyamoto et al, 2012 ), abscisic acid ( Liang et al, 2011 ), HaXS ( Erhart et al, 2013 ), TMP-HTag ( Ballister et al, 2014 ) and ATB-737 ( Hill et al, 2018 ) induce hetero-dimerization of proteins; 2) Symmetric molecules such as FK1012 ( Spencer et al, 1993 ), coumermycin ( Farrar et al, 1996 ) and (cyclosporin A) 2 ( Belshaw et al, 1996b ) induce homo-dimerization of proteins ( Table 1 ). For example, the natural product rapamycin has emerged as the biofunctional dimerizer to induce heterodimerization of proteins ( Choi et al, 1996 ; Liang et al, 1999 ; Bayle et al, 2006 ; Brown et al, 2015 ; Mangal et al, 2018 ; Courtney et al, 2021 ). The most prominent molecular feature of rapamycin is its two chemically distinct protein binding domains: one part of the molecule binds with high nanomolar affinity to the FK506-binding protein (FKBP12), the other molecular part to the FRB domain of mTOR, FRAP (FKBP-rapamycin associated protein), overall resulting in dimerization of the proteins involved.…”